Skip to content

News

Fresh growth opportunities open for MNCs

Peter Burnett answers questions from journalists on the sidelines of the Boao Forum for Asia Annual Conference 2026 in Boao, Hainan province, on Wednesday. ZHANG WEI/CHINA DAILY China’s green transition, innovation capabilities and policy continuity will create fresh opportunities for foreign firms to introduce their latest products and services during the 15th Five-Year Plan (2026-30)…

Hainan shares nuclear pearls of wisdom

A bird’s-eye view of the base. [Photo provided to CHINA DAILY] On a bright winter morning, veteran pearl farmer He Hanyong gently pried open a silver-lipped oyster. Inside, nestled against the iridescent mother-of-pearl, lay something extraordinary — not just an organic gem, but a symbol of an unlikely marriage between ecology and industry. “Look,” he…

Pinduoduo unveils in-house brand with 100b yuan investment plan

A consumer walks past an advertisement of e-commerce platform Pinduoduo at a shopping mall in Shanghai. [Photo provided to China Daily] China’s major e-commerce platform Pinduoduo said on Wednesday that it will invest 100 billion yuan ($13.9 billion) over the next three years to build a new self-operated brand initiative, as part of a broader…

Zhuhai port processes 2 million daily e-commerce packages for export

The import and export value through the Zhuhai port of the Hong Kong-Zhuhai-Macao Bridge increased rapidly in the first two months of 2026. [Photo by Lin Changfeng/for chinadaily.com.cn] At the Zhuhai port inspection site of the Hong Kong-Zhuhai-Macao Bridge, trucks loaded with e-commerce packages from all over the country arrive each day to be inspected…

China approves innovative breast cancer therapy by Daiichi Sankyo, AstraZeneca

Daiichi Sankyo and AstraZeneca announce on Friday that their co-developed innovative medicine, Enhertu, has been approved for use in China as a neoadjuvant treatment for early-stage breast cancer. [Provided to chinadaily.com.cn] Japan’s Daiichi Sankyo and the United Kingdom’s AstraZeneca announced on Friday that their co-developed innovative medicine, Enhertu, has been approved for use in China…

China considers measures against Mexico after trade probe

China has determined that certain Mexican trade restrictions targeting China constitute barriers to trade and investment, following an investigation launched last September, the Ministry of Commerce said on Wednesday. The probe found that measures taken by Mexico, including increased import tariffs on countries with which it does not have free trade agreements—including China—have restricted and…